Provided by Tiger Trade Technology Pte. Ltd.

CLIMB BIO INC

13.73
-0.8400-5.77%
Post-market: 13.860.1300+0.95%19:23 EDT
Volume:1.44M
Turnover:19.92M
Market Cap:786.19M
PE:-16.45
High:14.70
Open:14.58
Low:13.49
Close:14.57
52wk High:18.33
52wk Low:1.54
Shares:57.26M
Float Shares:41.60M
Volume Ratio:1.16
T/O Rate:3.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8347
EPS(LYR):-0.8974
ROE:-27.10%
ROA:-18.45%
PB:3.28
PE(LYR):-15.30

Loading ...

Climb Bio says FDA grants Fast Track designation for budoprutug in pMN

Reuters
·
Apr 07

Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy

THOMSON REUTERS
·
Apr 07

Climb Bio Inc - to Share Initial Phase 2 Data in Second Half of 2026

THOMSON REUTERS
·
Apr 07

Climb Bio Inc - Susan Altschuller to Serve as Principal Accounting Officer Effective April 30, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 04

Climb Bio SVP Finance Cindy Driscoll to exit; CFO Altschuller adds accounting role

Reuters
·
Apr 04

Climb Bio Initiated at Buy by B. Riley Securities

Dow Jones
·
Mar 24

Climb Bio Initiated at Buy by Truist Securities

Dow Jones
·
Mar 18

U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

Reuters
·
Mar 18

Climb Bio Inc : Raymond James Initiates Coverage With Strong Buy Rating; Target Price $25

THOMSON REUTERS
·
Mar 11

U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle

Reuters
·
Mar 11

Climb Bio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 10

Climb Bio price target raised to $15 from $11 at H.C. Wainwright

TIPRANKS
·
Mar 10

Climb Bio, Inc. : H.c. Wainwright Raises Target Price to $15 From $11

THOMSON REUTERS
·
Mar 10

U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, FedEx

Reuters
·
Mar 10

Wedbush Raises Price Target on Climb Bio to $14 From $12, Keeps Outperform Rating

MT Newswires Live
·
Mar 06

Climb Bio price target raised to $12 from $9 at Baird

TIPRANKS
·
Mar 06

Climb Bio Initiated at Outperform by Wedbush

Dow Jones
·
Mar 05

Wedbush Initiates Climb Bio at Outperform With $12 Price Target

MT Newswires Live
·
Mar 05

Climb Bio Inc : Wedbush Initiates Coverage With Outperform Rating; Target Price $12.00

THOMSON REUTERS
·
Mar 05

Climb Bio Q4 EPS $(0.26) Misses $(0.18) Estimate

Benzinga Earnings
·
Mar 05